• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » PerkinElmer tops forecasts with 43-cent adjusted Q4 profit

PerkinElmer tops forecasts with 43-cent adjusted Q4 profit

February 5, 2010 By MassDevice staff

Topping both analyst’s and its own prior estimates, adjusted fourth-quarter earnings at PerkinElmer Inc. (NYSE:PKI) rose handily despite a slight dip in revenues for the diagnostic and laboratory equipment maker.

Company executives said they were largely pleased with the results, noting that the Waltham, Mass.-based firm was able to top expectations in a tough market while also investing in several initiatives supporting future growth.

“We believe this balanced approach allowed us to exit 2009 stronger and better positioned strategically,” CEO Robert Friel said in a press release.

PerkinElmer said it also anticipates 2010 earnings to be in the range of 98 cents to $1.05 per share, with an organic revenue growth increasie in the low- to mid-single-digits, relative to 2009. The company reported an $85.6 million profit, or 73 cents per share, during 2009 on $1.8 billion in overall revenues.

During the three months ended Jan. 3, net earnings were $39.9 million, or 33 cents per share, on $498.3 million in revenues. That compares with a year-ago profit of $30.6 million, or 29 cents per share, on $499.9 million in sales. Revenues within PerkinElmer’s human health segment grew by about $300,000 during the quarter, reaching $198.2 million, helping offset a $1.9 million decline in sales by its environmental health unit.

Excluding items such as amortization of intangible assets and purchase accounting adjustments, earnings per share during the fourth quarter rose to 43 cents — beating consensus estimates and the company’s own guidance by 2 cents.

Currency translations and acquisitions combined to boost reported revenues by about $25 million during the fourth quarter, with a weak U.S. dollar working to ratchet up the reported results by about 4 percent. Adjusted operating profit for human health segment was $36.7 million, or about $300,000 higher than the fourth quarter of 2008.

Filed Under: Business/Financial News, Diagnostics, Lab Instruments & Supplies, MassDevice Earnings Roundup, News Well Tagged With: PerkinElmer Inc.

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy